1-20 of 23
Kerstin Schäfer-Eckart, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Remission and Survival after Single Versus Double Induction with 7+3 for Newly Diagnosed Acute Myeloid Leukemia: Results from the Planned Interim Analysis of Randomized Controlled SAL-Daunodouble Trial

Christoph Röllig, MD MSC, Björn Steffen, MD, Nael Alakel, MD, Regina Herbst, MD, Richard Noppeney, MD, Maher Hanoun, MD PhD, Zdenek Racil, MD PhD, Kerstin Schäfer-Eckart, MD, Alwin Krämer, MD, Andreas Neubauer, Professor Dr, Claudia D Baldus, MD, Christoph Schliemann, Prof., MD, Martin Kaufmann, MD, Jolana Mertova, Edgar Jost, Dirk Niemann, MD, Jan Novak, Stefan W Krause, Sebastian Scholl, Gerhard Held, Professor Dr, Stefani B. Parmentier, Tomáš Szotkowski, MD PhD, Pavel Zak, MD, Andreas Rank, PD Dr, Maxi Wass, MD, Sebastian Buske, Michael Kramer, Frank Fiebig, Annett Haake, Johannes Schetelig, MDMSc, Uwe Platzbecker, Christian Thiede, MD, Carsten Müller-Tidow, MD, Wolfgang E. Berdel, Prof., MD, Hubert Serve, MD PhD, Gerhard Ehninger, MD, Jiri Mayer, Martin Bornhäuser, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1–3.
https://doi.org/10.1182/blood-2020-140246
Published: 2020
Journal Articles

Time from Diagnosis to Treatment Does Not Affect Outcome in Intensively Treated Patients with Newly Diagnosed Acute Myeloid Leukemia

Christoph Röllig, MD MSC, Michael Kramer, M.Sc., Christoph Schliemann, Jan-Henrik Mikesch, MD, Björn Steffen, MD, Alwin Krämer, MD, Tim Sauer, MD, Mathias Hänel, MD, Regina Herbst, MD, Kerstin Schäfer-Eckart, MD, Richard Noppeney, MD, Edgar Jost, MD, Tim H Brümmendorf, MD, Stefan W Krause, MD, Volker Kunzmann, MD PhD, Hermann Einsele, MD, Sebastian Scholl, Andreas Hochhaus, MD, Lars R. Fransecky, MD, Martin Kaufmann, MD, Andreas Neubauer, MD, Dirk Niemann, MD, Markus Schaich, MD, Norbert Frickhofen, MD, Alexander Kiani, Frank Heits, MD, Ulrich Krümpelmann, Ulrich Kaiser, MD, Johannes Kullmer, Maxi Wass, MD, Stefan Klein, MD, Malte Von Bonin, Jan Moritz Middeke, MD, Christian Thiede, MD, Friedrich Stoelzel, MD, Johannes Schetelig, MDMSc, Gerhard Ehninger, MD, Claudia D Baldus, Carsten Müller-Tidow, MD, Uwe Platzbecker, Hubert Serve, MD, Martin Bornhäuser, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 13.
https://doi.org/10.1182/blood-2019-123717
Published: 2019
Journal Articles

Lenalidomide, Adriamycin and Dexamethasone (RAD) Versus Bortezomib, Lenalidomide and Dexamethasone (VRD) in Newly Diagnosed Multiple Myeloma (MM) - Post-Induction Response and MRD Results By Flow Cytometry and NGS from a Phase 3 Randomized Controlled Clinical Trial (RCT)

Thomas Stübig, MD, Christian Langer, MD, Monika Engelhardt, MD, Lars-Olof Mügge, MD, Florian Bassermann, MD PhD, Martin Schreder, MD, Kerstin Schäfer-Eckart, MD, Igor Wolfgang Blau, Denise Wolleschak, Albrecht Reichle, MD, Ivana Metzler, MD, Bernd Metzner, MDPhD, Christoph Rollig, MD MSC, Bernd Hertenstein, MD, Heinz Dürk, Harald Biersack, MD, Helge Menzel, MD, Tobias Dechow, Jan Schleicher, Martin Gramatzki, MD, Tim H. Brümmendorf, MD, Stephan Fuhrmann, Max Bittrich, MD, Franziska Appelt, Martina Müller, Jan Krönke, MD, Julia Reusch, Christian Schmidt, MD, Monika Brüggemann, MD, Swantje Held, Stefan Knop, Hermann Einsele, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1979.
https://doi.org/10.1182/blood-2018-99-116067
Published: 2018
Journal Articles

The Impact of Cytogenetics on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia: A Survey from the Acute Leukemia Working Party (ALWP) of EBMT

Monica Poiani, Myriam Labopin, MD, Dietrich W. Beelen, Johanna Tischer, Jürgen Finke, MD, Arne Brecht, MD, Edouard Forcade, MD, Arnold Ganser, MD, Jakob R. Passweg, MDMS, Helene Labussiere-Wallet, MD, Ibrahim Yakoub-Agha, MD PhD, Kerstin Schäfer-Eckart, MD, Nicolaus Kroeger, MD, Bruno Lioure, MD, Annalisa Ruggeri, MD, Jordi Esteve, MD PhD, Arnon Nagler, MD, Mohamad Mohty, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4639.
https://doi.org/10.1182/blood-2018-99-113799
Published: 2018
Journal Articles

Prospective Multicenter Phase 3 Study Comparing 5-Azacytidine (5-Aza) Induction Followed By Allogeneic Stem Cell Transplantation Versus Continuous 5-Aza According to Donor Availability in Elderly MDS Patients (55-70 years) (VidazaAllo Study)

Nicolaus Kroeger, Katja Sockel, MD, Christine Wolschke, MD, Wolfgang Bethge, MD, Richard F. Schlenk, MD, Dominik Wolf‎, MD, Michael Stadler, MD PhD, Guido Kobbe, Gerald Wulf, MD, Gesine Bug, Kerstin Schäfer-Eckart, MD, Christoph Scheid, MD, Florian Nolte, MD, Jan Krönke, MD, Matthias Stelljes, MD, Dietrich W. Beelen, Marion Heinzelmann, Detlef Haase, MD PhD, Hannes Buchner, Dr., Gabriele Bleckert, Dr., Uwe Platzbecker
Journal: Blood
Blood (2018) 132 (Supplement 1): 208.
https://doi.org/10.1182/blood-2018-99-115932
Published: 2018
Journal Articles

Clinical Characteristics and Outcome in IDH1/2 Mutant AML Patients - Analysis of 3898 Newly Diagnosed Patients with Acute Myeloid Leukemia

Jan Moritz Middeke, MD, Christoph Rollig, MD MSC, Michael Kramer, M.Sc., Alwin Kramer, MD, Tilman Bochtler, MD, Sebastian Scholl, MD, Andreas Hochhaus, MD, Edgar Jost, MD, Tim H. Brümmendorf, MD, Ralph Naumann, MD, Björn Steffen, MD, Volker Kunzmann, MD PhD, Hermann Einsele, MD, Markus Schaich, MD, Andreas Burchert, MD, Andreas Neubauer, Kerstin Schäfer-Eckart, MD, Christoph Schliemann, MD, Stefan W Krause, MD, Regina Herbst, MD, Mathias Hänel, MD, Norbert Frickhofen, MD, Richard Noppeney, MD, Ulrich Kaiser, MD, Claudia D. Baldus, MD, Martin Kaufmann, MD, Zdenek Racil, MD, Sebastian Stasik, PhD, Katja Sockel, MD, Malte von Bonin, MD, Carsten Müller-Tidow, Uwe Platzbecker, Wolfgang E. Berdel, MD, Jiri Mayer, MD, Hubert Serve, MD, Gerhard Ehninger, MD, Johannes Schetelig, MD MSc, Christian Thiede, MD, Friedrich Stoelzel
Journal: Blood
Blood (2018) 132 (Supplement 1): 1461.
https://doi.org/10.1182/blood-2018-99-118128
Published: 2018
Journal Articles

EZH2 Mutations and Impact on Clinical Outcome Analyzed in 1604 Patients with Acute Myeloid Leukemia

Sebastian Stasik, PhD, Jan Moritz Middeke, MD, Michael Kramer, M.Sc., Christoph Rollig, MD MSC, Alwin Krämer, MD, Sebastian Scholl, MD, Andreas Hochhaus, MD, Martina Crysandt, Tim H. Brümmendorf, MD, Ralph Naumann, MD, Björn Steffen, MD, Volker Kunzmann, MD PhD, Hermann Einsele, MD, Markus Schaich, MD, Andreas Burchert, MD, Andreas Neubauer, Kerstin Schäfer-Eckart, MD, Christoph Schliemann, MD, Stefan W Krause, MD, Regina Herbst, MD, Mathias Hänel, MD, Norbert Frickhofen, MD, Richard Noppeney, MD, Ulrich Kaiser, MD, Claudia D. Baldus, MD, Martin Kaufmann, MD, Zdenek Racil, MD, Uwe Platzbecker, Wolfgang E. Berdel, MD, Jiri Mayer, MD, Hubert Serve, MD, Carsten Müller-Tidow, Gerhard Ehninger, MD, Martin Bornhäuser, Johannes Schetelig, MD, Christian Thiede, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1528.
https://doi.org/10.1182/blood-2018-99-114421
Published: 2018
Journal Articles

The Addition of Sorafenib to Standard AML Treatment Results in a Substantial Reduction in Relapse Risk and Improved Survival. Updated Results from Long-Term Follow-up of the Randomized-Controlled Soraml Trial

Christoph Rollig, MD MSC, Hubert Serve, Andreas Hüttmann, MD, Richard Noppeney, MD, Carsten Müller-Tidow, Utz Krug, Claudia D. Baldus, MD, Christian H. Brandts, MD, Volker Kunzmann, MD PhD, Hermann Einsele, Alwin Krämer, MD, Kerstin Schäfer-Eckart, MD, Andreas Neubauer, MD, Andreas Burchert, MD, Aristoteles Giagounidis, MD, Stefan W. Krause, Andreas Mackensen, MD, Walter E. Aulitzky, MD, Regina Herbst, MD, Mathias Hänel, MD, Alexander Kiani, Norbert Frickhofen, MD, Johannes Kullmer, Ulrich Kaiser, MD, Hartmut Link, MD PhD, Thomas Geer, MD, Albrecht Reichle, MD, Christian Junghanss, MD, Roland Repp, MD, Frank Heits, MD, Heinz Albert Durk, Thomas Illmer, Martin Bornhäuser, MD, Markus Schaich, MD, Stefani Barbara Parmentier, MD, Martin Goerner, MD, Christian Thiede, MD, Malte von Bonin, MD, Johannes Schetelig, MD, Michael Kramer, M.Sc., Wolfgang E. Berdel, Gerhard Ehninger
Journal: Blood
Blood (2017) 130 (Supplement 1): 721.
https://doi.org/10.1182/blood.V130.Suppl_1.721.721
Published: 2017
Journal Articles

Induction Therapy for AML with 90 Mg/m² Daunorubicin Results in Higher Troponin T Serum Levels in Comparison to Treatment with 60 Mg/m² Daunorubicin

Stefan D Dendorfer, Michael Kramer, M.Sc., Katharina Schmidt-Brücken, Friedrich Stoelzel, MD, Regina Herbst, MD, Richard Noppeney, MD, Zdenek Racil, MD, Jiri Mayer, Prof, MD SCs, Björn Steffen, Tilman Bochtler, MD, Alwin Krämer, MD, Carsten Müller-Tidow, Kerstin Schäfer-Eckart, MD, Andreas Burchert, MD, Andreas Neubauer, MD, Claudia D. Baldus, MD, Christoph Schliemann, Martin Kaufmann, MD, Edgar Jost, Ralph Naumann, MD, Sebastian Scholl, MD, Andreas Hochhaus, MD, Hubert Serve, Wolfgang E. Berdel, Gerhard Ehninger, Martin Bornhäuser, MD, Christoph Rollig, MD MSC
Journal: Blood
Blood (2017) 130 (Supplement 1): 3901.
https://doi.org/10.1182/blood.V130.Suppl_1.3901.3901
Published: 2017
Journal Articles

Long-Term Efficacy of Reduced-Intensity Conditioning Compared to Standard Myeloablative Conditioning before Allogeneic Hemopoietic Cell Transplantation in Patients with Acute Myeloid Leukemia in First Complete Remission: 10-Year Follow-up of a Prospective, Open-Label Randomized Phase III Trial

Frederick Fasslrinner, MD, Johannes Schetelig, MD, Andreas Burchert, MD, Michael Kramer, M.Sc., Rudolf Trenschel, MD, Ute Hegenbart, Michael Stadler, MD PhD, Kerstin Schäfer-Eckart, MD, Michael Bätzel, Hans Eich, MD, Rita Engenhart-Cabillic, MD, Mechthild Krause, MD, Peter Dreger, MD, Andreas Neubauer, MD, Gerhard Ehninger, Dietrich W Beelen, MD PhD, Wolfgang E. Berdel, Timo Siepmann, MD, Matthias Stelljes, MD, Martin Bornhäuser, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4586.
https://doi.org/10.1182/blood.V130.Suppl_1.4586.4586
Published: 2017
Journal Articles

Real Life Experience with ATRA-Arsenic Trioxide Based Regimen in Acute Promyelocytic Leukemia - Updated Results of the Prospective German Intergroup Napoleon Registry

Uwe Platzbecker, MD, Eva Lengfelder, MD, Kerstin Schäfer-Eckart, MD, Katharina S Götze, MD, Michael Heuser, MD, Felicitas Thol, MD, Helmut R. Salih, MD, Mathias Hänel, MD, Karsten Spiekermann, Sonja Martin, MD, Sigrid Machherndl-Spandl, MD, Volker Kunzmann, MD, Andreas Jakob, MD, Hans-Joachim Tischler, MD, Dirk Niemann, MD, Joerg Mezger, MD, Tilmann Bochtler, MD, Stefan Krause, MD, Maike de Wit, MD, Claudia D. Baldus, MD, Richard Greil, MD, Jochen Greiner, Mark Ringhoffer, MD, Markus Radsak, MD, Mohammed Amen Wattad, MD, Wolff Schmiegel, MD, Elisabeth Koller, MD, Frank Heits, MD, Albrecht Reichle, MD, Stephan Kremers, MD, Andreas Hochhaus, MD, Nadezda Basara, MD, Dominik Wolf, MD, Martin Goerner, MD, Markus Schaich, MD, Harald Biersack, MD, Heinz Kirchen, MD, Thomas Kubin, MD, Gregor Aschauer, MD, Tanja Hesse, MD, Hartmut Link, MD PhD, Heinz Duerk, MDPhD, Dorit Kuerschner, MD, Walter Fiedler, MD, Bernd Hertenstein, MD, Martin Puttrich, Michael Kramer, M.Sc., Michaela Sauer, Wolfgang Hiddemann, Ulrich Duehrsen, MD, Hubert Serve, Christian Thiede, MD, Arnold Ganser, MD, Tim H. Brummendorf, MD, Konstanze Dohner, MD, Martin Bornhäuser, MD, Richard F. Schlenk, MD, Christoph Rollig, MD MSC, Hartmut Döhner, MD, Gerhard Ehninger, Peter Paschka, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2618.
https://doi.org/10.1182/blood.V130.Suppl_1.2618.2618
Published: 2017
Journal Articles

Outcome of Third Salvage Autologous Stem Cell Transplantation in Multiple Myeloma

Laurent Garderet, MD, Simona Iacobelli, Anja van Biezen, Linda Koster, Peter Dreger, MD, Jan-Erik Johansson, MD PhD, Xavier Leleu, Michael Potter, Marta Krejci, MD PhD, Christian Peschel, MD, Jakub Radocha, MD PhD, Arnold Ganser, MD, Bernd Metzner, Nicoli Paoli, Kerstin Schäfer-Eckart, MD, David Pohlreich, Pascal Lenain, Mariella Grasso, MD, Denis Caillot, Hermann Einsele, MD, Henrik Sengeloev, MD, Nathalie Meuleman, MD PhD, Fabio Ciceri, MD, Stefan Schönland, MD, Nicolaus Kröger, MD
Journal: Blood
Blood (2016) 128 (22): 993.
https://doi.org/10.1182/blood.V128.22.993.993
Published: 2016
Journal Articles

Real Life Experience with ATRA-Arsenic Trioxide Based Regimen in Acute Promyelocytic Leukemia - Updated Results of the Prospective German Intergroup Napoleon Registry

Uwe Platzbecker, MD, Eva Lengfelder, MD, Katharina S Goetze, MD, Christoph Röllig, MD, Michael Kramer, Michaela Sauer, Nadine Albers, Michael Heuser, Hartmut Link, MD PhD, Kerstin Schäfer-Eckart, MD, Sonja Martin, MD, Stefan W. Krause, MD, Mathias Hänel, MD, Tilmann Bochtler, MD, Andreas Jakob, MD, Albrecht Reichle, MD, Harald Biersack, MD, Claudia D. Baldus, MD, Martin Goerner, MD, Nadezda Basara, MD, Joerg Mezger, MD, Ralph Naumann, MD, Dorit Kuerschner, MD, Maike de Wit, Florian Nolte, MD, Mark Ringhoffer, MD, Hans-Joachim Tischler, MD, Jochen Greiner, Stephan Kremers, Sigrid Machherndl-Spandl, MD, Elisabeth Koller, MD, Mohammad Amen Wattad, MD, Gregor Aschauer, MD, Markus Radsak, MD, Thomas Kubin, MD, Helmut Salih, MD, Frank Heits, MD, Dominik Wolf, MD, Christian Thiede, MD, Hubert Serve, MD, Ulrich Duehrsen, MD, Andreas Hochhaus, MD, Tim H. Brümmendorf, MD, Martin Bornhäuser, MD, Hartmut Döhner, MD, Gerhard Ehninger, MD, Richard F. Schlenk, MD
Journal: Blood
Blood (2016) 128 (22): 2815.
https://doi.org/10.1182/blood.V128.22.2815.2815
Published: 2016
Journal Articles

Long Term Follow up and Impact of Comorbidity Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory AML - Lessons Learned from the Prospective Bridge Trial -

Jan Moritz Middeke, MD, Regina Herbst, MD, Stefani Barbara Parmentier, MD, Gesine Bug, MD, Mathias Hänel, MD, Gernot Stuhler, Kerstin Schäfer-Eckart, MD, Wolf Rösler, MD, Stefan A. Klein, MD, Wolfgang Bethge, MD, Nael Alakel, MD, Markus Schaich, MD, Anke Morgner, MD, Michael Kramer, MSc, Katja Sockel, MD, Malte von Bonin, MD, Friedrich Stölzel, MD, Uwe Platzbecker, MD, Christoph Röllig, MD, Christian Thiede, MD, Gerhard Ehninger, MD, Martin Bornhäuser, MD, Johannes Schetelig, MD MSc
Journal: Blood
Blood (2016) 128 (22): 4692.
https://doi.org/10.1182/blood.V128.22.4692.4692
Published: 2016
Journal Articles

Allogeneic Stem Cell Transplantation Improves Survival in Patients with FLT 3-ITD-Negative and NPM 1-Wild Type Intermediate Risk (ELN) Acute Myeloid Leukemia

Katharina Heidrich, MD, Christian Thiede, MD, Kerstin Schäfer-Eckart, MD, Norbert Schmitz, MD, Walter E Aulitzky, MD, Alwin Krämer, MD, Wolf Rösler, MD, Mathias Hänel, MD, Hermann Einsele, MD, Claudia D. Baldus, MD, Ralf U Trappe, MD, Friedrich Stölzel, MD, Jan Moritz Middeke, MD, Christoph Röllig, MD, Michael Kramer, MSc, Hubert Serve, MD, Wolfgang E Berdel, MD, Gerhard Ehninger, MD, Martin Bornhäuser, MD, Johannes Schetelig, MD MSc
Journal: Blood
Blood (2016) 128 (22): 3493.
https://doi.org/10.1182/blood.V128.22.3493.3493
Published: 2016
Journal Articles

Azacitidine Followed By Intensive Induction/Consolidation Chemotherapy in Older Patients with Acute Myeloid Leukemia (AML): Results from the Randomized AML-AZA Trial of the Study Alliance Leukemias (SAL)

Carsten Müller-Tidow, MD, Petra Tschanter, MD, Utz Krug, MD, Stefanie Goellner, PhD, Christoph Röllig, MD, Christian Thiede, MD, Anja Koschmieder, Martin Dugas, PhD, Joachim Gerss, PhD, Trude Butterfaß-Bahloul, Ruth Wagner, Stefan W. Krause, MD, Ulrich Kaiser, Volker Kunzmann, MD, Björn Steffen, MD, Richard Noppeney, MD, Wolfgang Herr, MD, Claudia D Baldus, Norbert Schmitz, MD, Katharina Götze, Albrecht Reichle, Martin Kaufmann, MD, Andreas Neubauer, MD, Kerstin Schäfer-Eckart, MD, Mathias Hänel, MD, Rudolf Peceny, MD, Haack Bea, Lilly Meredith, Norbert Frickhofen, MD, Michael G Kiehl, MD, Aristoteles A.N. Giagounidis, MD PhD, Martin Görner, Roland Repp, MD, Ralph Naumann, MD, Hartmut Link, MDPhD, Alexander Kiani, MD, Steffen Koschmieder, MD, Tim H. Brümmendorf, MD, Hubert Serve, MD, Gerhard Ehninger, MD, Wolfgang E Berdel, MD
Journal: Blood
Blood (2014) 124 (21): 946.
https://doi.org/10.1182/blood.V124.21.946.946
Published: 2014
Journal Articles

Response to Lenalidomide, Doxorubicin and Dexamethasone (RAD) in Newly Diagnosed Multiple Myeloma Is Independent of Cytogenetic Risk and Retained after Double Stem Cell Transplant

Stefan Knop, MD, Christian Langer, MD, Monika Engelhardt, MD, Lars-Olof Mügge, MD, Albrecht Reichle, Wolf Rösler, MD, Florian Bassermann, MD, Bernd Hertenstein, MD, Isrid Sturm, MD, Christoph Röllig, MD, Helmut Ostermann, MD, Kerstin Schäfer-Eckart, MD, Mark Ringhoffer, MD, Andreas Günther, Christian Junghanss, MD, Harald Biersack, MD, Susanne Strifler, MD, Andreas Bachinger, Hermann Einsele, MD, Ralf C. Bargou
Journal: Blood
Blood (2014) 124 (21): 177.
https://doi.org/10.1182/blood.V124.21.177.177
Published: 2014
Journal Articles

Improved Outcome with ATRA-Arsenic Trioxide Compared to ATRA-Chemotherapy in Non-High Risk Acute Promyelocytic Leukemia – Updated Results of the Italian-German APL0406 Trial on the Extended Final Series

Uwe Platzbecker, MD, Giuseppe Avvisati, MD, Gerhard Ehninger, MD, Laura Cicconi, MD, Christian Thiede, MD, Felicetto Ferrara, MD, Sonia Maria Orlando, B.Sc., Marco Vignetti, MD, Giorgina Specchia, MD, Marco Sborgia, Eros Di Bona, MD, Massimo Breccia, MD, Elisa Cerqui, MD, Konstanze Döhner, MD, Walter Fiedler, MD, Marie von Lilienfeld-Toal, MD, Bernd Hertenstein, MD, Helmut R. Salih, MD, Mohammed Wattad, MD, Michael Lübbert, Christian H. Brandts, MD, Mathias Hänel, MD, Norbert Schmitz, MD, Hartmut Link, MDPhD, Mariadomenica Divona, B.Sc., Chiara Frairia, MD, Enrico Maria Pogliani, MD, Claudio Fozza, MD, Alfonso Maria D'Arco, MD, Nicola Di Renzo, MD, Agostino Cortelezzi, MD, Francesco Fabbiano, MD, Paola Fazi, MD, Johannes Kullmer, MD, Walter E. Aulitzky, MD, Stefan W. Krause, MD, Hans Salwender, MD, Kerstin Schäfer-Eckart, MD, Markus P. Radsak, MD, Arnold Ganser, Hartmut Döhner, MD, Sergio Amadori, MD, Franco Mandelli, MD, Richard F. Schlenk, MD, Francesco Lo-Coco, MD
Journal: Blood
Blood (2014) 124 (21): 12.
https://doi.org/10.1182/blood.V124.21.12.12
Published: 2014
Journal Articles

– Updated Results from the Bridge Trial: Long-Term Survival and Impact of Donor Availability – Clofarabine Salvage Therapy Prior to Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory AML

Jan Moritz Middeke, MD, Regina Herbst, MD, Stefani B Parmentier, MD, Gesine Bug, MD, Mathias Hänel, MD, Gernot Stuhler, MD, Kerstin Schäfer-Eckart, MD, Wolf Rösler, MD, Stefan A. Klein, Wolfgang Bethge, MD, Ulrich Bitz, MD, Nael Alakel, MD, Markus Schaich, MD, Anke Morgner, MD, Michael Kramer, PhD, Uwe Platzbecker, MD, Christoph Röllig, MD, Christian Thiede, MD, Gerhard Ehninger, MD, Martin Bornhäuser, MD, Johannes Schetelig, MD M. Sc,
Journal: Blood
Blood (2014) 124 (21): 1204.
https://doi.org/10.1182/blood.V124.21.1204.1204
Published: 2014
Journal Articles

Sorafenib Versus Placebo in Addition to Standard Therapy in Younger Patients with Newly Diagnosed Acute Myeloid Leukemia: Results from 267 Patients Treated in the Randomized Placebo-Controlled SAL-Soraml Trial

Christoph Röllig, MD, Carsten Müller-Tidow, MD, Andreas Hüttmann, MD, Richard Noppeney, MD, Volker Kunzmann, MD, Claudia D Baldus, MD, Christian H. Brandts, MD, Alwin Krämer, MD, Kerstin Schäfer-Eckart, MD, Andreas Neubauer, MD, Stefan W. Krause, MD, Aristoteles Giagounidis, MD PhD, Walter E. Aulitzky, MD, Martin Bornhäuser, MD, Markus Schaich, MD, Stefani B Parmentier, MD, Christian Thiede, MD, Malte von Bonin, MD, Johannes Schetelig, MD M. Sc,, Michael Kramer, PhD, Hubert Serve, MD, Wolfgang E Berdel, MD, Gerhard Ehninger, MD
Journal: Blood
Blood (2014) 124 (21): 6.
https://doi.org/10.1182/blood.V124.21.6.6
Published: 2014